Wegovy Demand Busts Through Novo Nordisk’s Expanded Capacity

 
• By Jessica Merrill

Novo Nordisk said it would temporarily reduce production of the lower starting dose of Wegovy even as a second contract manufacturer has come online in April.

fist banging through a wall
Wegovy demand continues to outpace supply • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas